Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

8-15-2021

Differential localization patterns of pyruvate kinase isoforms in
murine naïve, formative, and primed pluripotent states
Joshua G. Dierolf
Schulich School of Medicine & Dentistry

Andrew J. Watson
Schulich School of Medicine & Dentistry

Dean H. Betts
Schulich School of Medicine & Dentistry, dean.betts@schulich.uwo.ca

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Dierolf, Joshua G.; Watson, Andrew J.; and Betts, Dean H., "Differential localization patterns of pyruvate
kinase isoforms in murine naïve, formative, and primed pluripotent states" (2021). Paediatrics
Publications. 807.
https://ir.lib.uwo.ca/paedpub/807

Experimental Cell Research 405 (2021) 112714

Contents lists available at ScienceDirect

Experimental Cell Research
journal homepage: www.elsevier.com/locate/yexcr

Research article

Differential localization patterns of pyruvate kinase isoforms in murine
naïve, formative, and primed pluripotent states
Joshua G. Dierolf a, Andrew J. Watson a, b, c, 1, Dean H. Betts a, b, c, 1, *
a

Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, Canada
Department of Obstetrics and Gynecology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, Canada
c
The Children’s Health Research Institute (CHRI), Lawson Health Research Institute, London, Canada
b

A R T I C L E I N F O

A B S T R A C T

Keywords:
Colocalization
Confocal microscopy
Embryonic stem cells
Metabolism
Pluripotency
Pyruvate kinase muscle isoforms 1/2

Mouse embryonic stem cells (mESCs) and mouse epiblast stem cells (mEpiSCs) represent opposite ends of the
pluripotency continuum, referred to as naïve and primed pluripotent states, respectively. These divergent
pluripotent states differ in several ways, including growth factor requirements, transcription factor expression,
DNA methylation patterns, and metabolic profiles. Naïve cells employ both glycolysis and oxidative phosphor
ylation (OXPHOS), whereas primed cells preferentially utilize aerobic glycolysis, a trait shared with cancer cells
referred to as the Warburg Effect. Until recently, metabolism has been regarded as a by-product of cell fate,
however, evidence now supports metabolism as being a driver of stem cell state and fate decisions. Pyruvate
kinase muscle isoforms (PKM1 and PKM2) are important for generating and maintaining pluripotent stem cells
(PSCs) and mediating the Warburg Effect. Both isoforms catalyze the final, rate limiting step of glycolysis,
generating adenosine triphosphate and pyruvate, however, the precise role(s) of PKM1/2 in naïve and primed
pluripotency is not well understood. The primary objective of this study was to characterize the cellular
expression and localization patterns of PKM1 and PKM2 in mESCs, chemically transitioned epiblast-like cells
(mEpiLCs) representing formative pluripotency, and mEpiSCs using immunoblotting and confocal microscopy.
The results indicate that PKM1 and PKM2 are not only localized to the cytoplasm, but also accumulate in dif
ferential subnuclear regions of mESC, mEpiLCs, and mEpiSCs as determined by a quantitative confocal micro
scopy employing orthogonal projections and airyscan processing. Importantly, we discovered that the subnuclear
localization of PKM1/2 changes during the transition from mESCs, mEpiLCs, and mEpiSCs. Finally, we have
comprehensively validated the appropriateness and power of the Pearson’s correlation coefficient and Manders’s
overlap coefficient for assessing nuclear and cytoplasmic protein colocalization in PSCs by immunofluorescence
confocal microscopy. We propose that nuclear PKM1/2 may assist with distinct pluripotency state maintenance
and lineage priming by non-canonical mechanisms. These results advance our understanding of the overall
mechanisms controlling naïve, formative, and primed pluripotency.

1. Introduction
Pluripotent stem cells (PSCs) have the capacity for indefinite selfrenewal and the potential to differentiate into the cell types of all
three germ layers including the germ line [1]. The potency of PSCs, such
as embryonic stem cells (ESCs), exists within a continuum with opposite

ends described as naïve and primed pluripotent states [1]. In mice, naïve
mESCs are derived from the inner cell mass (ICM) of an early, embryonic
day (E)3.5–4.5, blastocyst-stage embryo, whereas primed mouse
epiblast stem cells (mEpiSCs) are derived later from the epiblast of
E5.0–8.0 post-implantation embryos [2–6]. However, when cultured in
vitro, mEpiSCs more closely resemble the epiblast of E7.25–8.0 embryos

Abbreviations: (h/m)ESC, (human/mouse) Embryonic stem cell; ICM, Inner cell mass; MEF, Mouse embryonic fibroblasts; MOC, Manders’s overlap coefficient; (m)
EpiLC, (mouse) Epiblast-like cell; (m)EpiSC, (mouse) Epiblast stem cell; PCC, Pearson’s correlation coefficient; PSC, Pluripotent stem cell; PKM1/2, pyruvate kinase
muscle isoforms 1 and 2; QCA, Quantitative colocalization analysis; REAP, Rapid, efficient, and practical.
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[2,4,7,8]. Human ESCs (hESCs) have traditionally been stabilized at the
primed pluripotent state, however, a naïve hESC line has been recently
derived [9]. Between the ends of the pluripotent continuum exists a
recently described intermediate state called the ‘formative pluripotent
state’ [10,11]. Formative pluripotency is an executive phase and may
represent the gene expression patterns and attributes of mouse epiblast
cells within the E5.5–6.25 embryo [2]. Like naïve and primed PSCs,
formative PSCs also express NANOG, OCT4, and SOX2 [12–14]. How
ever, unlike naïve and primed PSCs, the formative mouse epiblast-like
cells (mEpiLCs) can efficiently differentiate into primordial germ
cell-like cells when presented with the appropriate growth factors, such
as bone morphogenetic protein 4 [2,15]. Each pluripotent state has
several distinguishing features such as unique morphology, growth
factor dependencies, gene expression profiles, epigenetic status, and
metabolic preferences. [1,2] Morphologically, naïve PSCs are more
rounded in appearance and grow as colonies with glistening edges
compared to flattened primed PSC colonies [1]. This hemispherical
morphology of naïve cells is largely due to greater Cdh1 expression,
which can be replicated in mEpiSCs overexpressing Cdh1 [16]. Culture
of mESCs requires leukemia inhibitory factor (LIF), which promotes
‘ground state’ naïve pluripotency and resists differentiation through
activation of the transcription factor STAT3 [17]. Stabilizing naïve
pluripotency requires LIF and the addition of two small molecule in
hibitors (LIF/2i) of MEK1/2 (PD00032) and glycogen synthase kinase-3
(CHIR99021) [18,19]. Formative cells can be chemically transitioned
from mESCs to mouse epiblast-like cells (mEpiLCs) over 48 h as a
transient and heterogenous population [14,20]. Recently, a stable line of
formative state PSCs has been derived using Tankyrase inhibitor open
ing the doors to improved models of developmental stem cell research
and primordial germ cell differentiation studies [21]. To maintain
primed pluripotency and exit the naïve state, mEpiSCs and chemically
transitioned mEpiLCs are cultured with ACTIVIN-A and FGF-2. While
naïve and primed cells express core pluripotency associated genes Oct4,
Sox2, and Nanog, both states differ in transcriptional programs with
Rex1, Esrrb, Dppa3, Klf2/4/5, Tcfcp2l1, and Pecam delineating the
naïve state, and Zic2, T (Brachyury) and Cer1, to list a few, dis
tinguishing the primed pluripotent state [2]. The formative pluripotent
state is reported to highly express Lef1, Pou1fc, and Dnmt3 [22]. Naïve
and primed pluripotent states also differ in terms of their epigenetic
landscape, including X-activation and chromatin methylation status
[23]. Female primed PSCs display random X chromosome inactivation,
whereas naïve PSCs display activation of both X chromosomes [24].
Relative to primed cells, naïve PSCs contain larger regions of active
chromatin as indicated by higher levels of H2k4me3 and histone acet
ylation [25,26]. Importantly, naïve and primed PSCs also differ in terms
of their metabolic preferences. [27] Naïve cells are characterised as
being metabolically bivalent, utilizing both glycolytic and oxidative
phosphorylation (OXPHOS) processes, whereas primed cells are pref
erentially glycolytic [27]. Even when cultured in oxygen rich conditions,
primed PSCs utilize aerobic glycolysis and display low OXPHOS gene
expression, which is characteristic of the Warburg Effect that is activated
in many cancer cells [28].
Cells exhibiting the Warburg Effect consume elevated glucose and
direct increased levels of pyruvate towards lactate formation. [29]
Glycolysis is elevated in most cancer cells to increase precursors
necessary for enhancing anabolic processes rather than generating ATP
[30]. Glucose oxidation by OXPHOS still produces the bulk of ATP in
most cancer cells with anaplerotic flux of metabolic intermediates pro
duced by glutaminolysis and lactic acid fermentation into the TCA cycle,
including α-ketoglutarate and even lactate respectively [31]. The
sourcing of metabolites for ATP production appears to be dependent on
the surrounding microenvironments and cancer subtype [32]. For
example, non-small cell lung cancer (NSCLC) cells illustrate metabolic
heterogeneity and preferential aerobic and non-aerobic metabolic pro
cesses [32]. Within NSCLC cells, elevated lactate is used a carbon source
in the TCA cycle and increased expression of pyruvate carboxylase

promotes higher levels of anaplerotic processes feeding into the TCA
cycle compared to normal lung tissue [32]. Misconceptions in dis
tinguishing the concepts of anabolic processes for cellular proliferation
and energy generation relating to the Warburg Effect need to be tackled
not only in cancer research but also in stem cell research [30].
The Warburg Effect is orchestrated by an upregulation of key tran
scription factors including: Oct4, c-Myc, Hif-1, and Nfb, along with the
glycolytic genes: Hk2, Pgm, Pdk, and pyruvate kinase muscle isoform 2
(Pkm2) [33]. When upregulated, these aerobic glycolysis drivers
enhance anabolism and ATP generation to boost glycolytic flux [31,34].
It is hypothesized that the high glycolytic flux of mESC maintains their
high proliferative capacity, and as such, cellular metabolic state should
be considered as a mediator of pluripotency and as a regulator of gene
expression controlling cell proliferation and differentiation [35,36].
While metabolism has traditionally been viewed as a by-product of cell
fate decisions, the manipulation of metabolic genes and their products in
stem cells can promote or resist cellular differentiation and reprog
ramming [27,37,38]. Thus, the developmental progression of naïve-
to-primed transitioning occurs in synchrony with metabolic
programming to influence cell fate and pluripotent state as both a driver
and a passenger [39].
Recently, pyruvate kinase muscle isoforms 1 and 2 (PKM1/2) have
been implicated in regulating pluripotency, proliferation, and in the
generation of pluripotent stem cells during reprogramming [40]. PKM1
and PKM2 are the metabolic enzymes responsible for catalyzing the final
rate limiting step of glycolysis by directing pyruvate towards either a
lactate or acetyl-CoA fate [41,42]. Mammals express four tissue specific
pyruvate kinase isozymes; M1, M2, L, and R, each with unique proper
ties and tissue expression patterns to meet specific metabolic demands
[43]. PKM1/2 are alternatively spliced isoforms from the PKM gene, and
both PKL and PKR are encoded by the PKLR gene [41]. The M1 and M2
isoforms are spliced by three different heterogeneous nuclear ribonu
cleoproteins; hnRNPI/hnRNP1/hnRNP2 that involve the inclusion of
exon 9 or 10, respectively [44]. PKM1/2 activity is regulated by
homotropic and heterotropic allosteric interactions with fructose 1,
6-bisphosphate (FBP) and phosphoenolpyruvate respectively [45,46].
PKM1 is expressed primarily in somatic cells, whereas fetal tissues along
with essentially all cancer cell types exhibit elevated PKM2 with certain
types of tumors such as glioblastomas displaying a complete isoform
switch from PKM1 to PKM2 [47]. The elevated PKM2 found in cancer
cells is predominantly the inactive PKM2 homodimer form, which is due
to pulsatile phosphofructokinase [48]. The active homotetramer is
typically bound to its cofactor FBP, however, when the PKM2 homo
dimer is phosphorylated (Y105) by the oncogenic linked fibroblast
growth factor receptor type 1, the homotetrameric configuration is
disrupted [42,49]. This interrupts glucose oxidation and increases
glycolysis and lactate production in aerobic glycolytic preferential
cancer cells, even in the presence of abundant oxygen levels. In contrast,
PKM1 operates as a constitutively active homotetramer without a
described allosteric binding site [50].
PKM2 has additional non-canonical roles including its function as a
protein kinase, cytosolic receptor, transcriptional co-activator, and is
also implicated in cytokinesis and chromosome segregation [51,52].
PKM2 can form a complex with OCT4 resulting in decreased OCT4
transcriptional activity and stemness with increased apoptosis and dif
ferentiation [53,54]. Studies also indicate that the interaction of PKM2
and OCT4 affects mitosis and tumor energy production [55]. PKM2 is
implicated in pluripotency through its interaction and transcriptional
regulation of OCT4 in hESCs [56]. Knockdown of PKM2 in hESCs
exhibited no change in lactate production or glucose uptake, however,
OCT4 expression decreased substantially [56]. PKM2 is observed in the
nuclei of the hESCs cultured under both normoxic (20%), and low (5%)
oxygen conditions, but a significant reduction in PKM2 expression was
observed under normoxic conditions [56]. Overexpression of either
PKM1 or PKM2 results in increased transcript abundance of the plu
ripotency associated genes; Eras, Rex1, and Nanog in mESCs [40]. Upon
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knockdown of total PKM, pluripotency associated gene transcript
abundance also decreases, but self-renewal and morphology appears
unperturbed [40]. During reprogramming of somatic cells into iPSCs,
both PKM1 and PKM2 are upregulated within the first 8 days [40]. The
knockdown of total PKM during this period hinders reprogramming and
overexpression of PKM2 significantly increases the generation of iPSC
colonies [40]. PKM1 was originally thought to be expressed in
non-proliferative tumors, however, PKM1 has recently been localized in
the nuclei of hepatoma (HepG2 and SMMC-7721 cell lines) cells
following Oroxylin A (OA) treatment, this localization was concluded to
promote cellular differentiation to hepatocytes-like cells [57,58].
The mechanisms controlling PKM1 and PKM2 nuclear translocation
are largely unknown, however, PKM1 may complex with hepatocyte
nuclear factor 4 (HNF4), and this can be enhanced with the addition of
the drug OA and the oncogene JMJD5 is implicated in the nuclear
translocation of PKM2 [57,59]. Nuclear translocation of PKM2 is well
supported by fluorescent imaging and nuclear/cytoplasmic fraction
ation [60–64]. However, typical confocal image analysis employing
visual interpretation of overlaid fluorescent images is a purely qualita
tive means of spatial localization. Accurate quantitative measurement of
spatial localization can effectively be quantified by a well-controlled
comparison of two fluorophores to determine the degree of colocaliza
tion [65]. Quantitative colocalization analysis (QCA) is commonly
divided into two metrics representing the relationship between two
fluorophores, these measures are the degree of overlap and correlation
[66]. The degree of spatial location by overlapping images was first
quantified by Otsu in 1979 where pixels of two images were overlapped
after applying a threshold [67]. Manders’s overlap coefficient (MOC)
better distinguishes pixels ignored from the threshold from higher in
tensity pixels but at the cost of being influenced by autofluorescence and
an insensitively to differences between the signal-to-noise ratios of the
two fluorophores [68,69]. While the MOC is a measure of co-occurrence
of two fluorophores, within the spatially shared regions of a cell, two
markers may interact or share a similar trend in intensity localization
and may be functionally related or interact. Thus, the colocalization
metric of correlation can indicate that two fluorophores share an asso
ciative relationship [69]. The Pearson correlation coefficient (PCC)
compares the variation of signal intensity between the intersection of
two images considering the total population of pixels [69]. As such, this
calculation can determine the direction of linear association between the
fluorophores [69,70].
Both MOC and the PCC are commonly used to quantify fluorescent
protein spatial overlap and correlation [71]. Despite the accuracy and
power of QCA, this technique has not been utilized to its full extent,
especially so, in its application to measuring spatial localization of
proteins in pluripotent stem cells [66]. This may be due to an on-going
debate within the QCA field over the correct use and interpretation of
overlap and correlation metrics [69,72,73]. Thus, our study contrasted
both PCC versus MOC in our analysis of PKM1/2 colocalization with
nuclear and cytoplasmic protein markers during naïve, formative, and
primed pluripotency within mouse ES cell cultures [74].
We have, for the first time, comprehensively characterized the sub
cellular localization and expression patterns of PKM1 and PKM2 iso
forms during transition from naïve, through the formative and onto the
primed murine embryonic pluripotent states. We accomplished this
characterization by optimizing a confocal microscopy colocalization
approach comparing correlation and co-occurrence of PKM1 and PKM2
localization to nuclear localized OCT4 and cytoplasmic localized
GAPDH. Degrees of colocalization were then applied to our measured
values of overlap and correlation using qualified ranges indicating a
spectrum of ‘very weak’ to ‘very strong’ variables of colocalization [74].
Using these approaches, we report an elevated nuclear presence of
PKM1 and PKM2 in naïve mESCs, formative state mEpiLCs and primed
mEpiSCs as assessed by spatial overlap of PKM1 and PKM2 localization
to OCT4 localization. We also report a moderate association of PKM1
and PKM2 to OCT4 localization in naïve mESCs, and a strong association

between PKM1 and OCT4 in formative mEpiLCs. Together, our results
suggest a novel, non-canonical role for PKM1 in pluripotent stem cells.
2. Materials and methods
2.1. Antibody specificity
Rabbit polyclonal antibodies specific for PKM1 and PKM2 (Pro
teintech 15821-1-AP, 15822-1-AP) were used to distinguish between
PKM1 and PKM2 protein localization and abundance in this study. These
PKM1 and PKM2 antibodies recognize the corresponding immunogens
of LVRASSHSTDLMEAMAMGSV and LRRLAPITSDPTEATAVGAV,
respectively, and have been knockdown-verified confirming their iso
form specificity (Nakatsu et al., 2015; Horiuchi et al., 2017; Christofk
et al., 2008; Ma et al., 2019; Jianan Chen et al., 2018).
2.2. Feeder cell derivation and culture conditions
Mouse embryonic fibroblasts (MEFs) (CF1 cell line, ThermoFisher)
derived from E12.5 mouse embryos were plated and expanded on 0.1%
porcine gelatin (Sigma G2500) coated dishes and irradiated (8000 rads).
Irradiated MEFs were cultured in media containing the following:
DMEM (ThermoFisher 11960044), 8.9% Qualified FBS (ThermoFisher
12483020, lot# 1936657), 1.1% MEM NEAA (100x) (ThermoFisher
11140050), 1.1% GlutaMAX (ThermoFisher 35050061). Irradiated
MEFs were plated on 0.1% gelatin dishes and cultured for a minimum of
1 h prior to mEpiSC plating for immunofluorescence and 24 h for all
other molecular analyses.
2.3. Stem cell culture conditions
Feeder-free, naïve, mouse embryonic stem cells (mESCs, R1 strain –
129X1 x 129S1; provided courtesy of Dr. Janet Rossant, Hospital for Sick
Children, Toronto, Canada), feeder-free, primed-like mouse epiblast-like
cells (mEpiLCs, chemically converted R1 mESCs) and primed mouse
epiblast stem cells (mEpiSCs, strain – 129S2; also provided by Dr. Janet
Rossant) were cultured in the following base media; a 1:1 mixture of
KnockOut DMEM/F12 (ThermoFisher 12660012) and Neurobasal
Media (ThermoFisher 21103049) with 0.1% 2-Mercaptoethanol (Gibco
21,985–029), 0.25% GlutaMAX (ThermoFisher 35050061), 1.0% N2
Supplement (100x) (ThermoFisher 17,502,048), 2.0% B27 Supplement
(50x) (ThermoFisher 17,504,044). Base media for the culture of mESCs
were supplemented with 1000 units/mL ESGRO Recombinant mouse
LIF protein (EMD Millipore ESG1107), and 2i small molecule inhibitors:
1 μM PD0325901 (Reagents Direct 39-C68) and 3 μM CHIR99021 (Re
agents Direct 27-H76). Base media for the culture of mEpiLCs and
mEpiSCs were supplemented with 20 ng/mL Activin A from mouse
(Sigma-Aldrich SRP6057) and 12 ng/mL Fgf-2 from mouse (SigmaAldrich SRP3038). mESCs were passaged using Accutase (STEMCELL
Technologies 07920) and centrifuged at 244 rcf for 5 min. Primed mouse
epiblast stem cells were cultured in the base medium and supplements as
mEpiLCs were along with a substratum of irradiated mouse embryonic
fibroblasts (MEFs). One hour prior to passaging, the growth medium was
replaced. Passaging was completed using Gentle Cell Dissociation Buffer
(Gibco 13,151–014) for 5 min at room temperature. Lifted cells were
then centrifuged at 244 rcf for 3 min and plated at a density of 1:12 onto
fibronectin coated dishes with MEFs. RNA and protein abundance
studies were completed by excluding MEFS for feeder-free conditions
and passaging mEpiSCs with StemPro™ Accutase™ (Thermo Fisher
A1110501) to ensure only MEF free lysates were used. Additionally,
during the preliminary work for this study it was clear that the MEF
feeder cells supporting the mEpiSCs, express the PKM isoforms in
abundance. We weaned our mEpiSCs off irradiated MEFs by gentle
enzymatic passaging onto fibronectin over two passages, this resulted in
a clean and healthy population of feeder-free mEpiSCs ready for protein
abundance studies.
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2.4. Real-time quantitative qRT-PCR

room temperature PBS(+/+). Cells were then blocked in 10% animal
serum of the host-species of the secondary antibody, diluted in 0.1% PBS
(+/+)-Tween 20 (PBST) for 30 min. Primary antibody was diluted in
10% animal serum of the host-species of secondary antibody, diluted
with 0.1% PBST overnight. Following primary incubation, cells were
washed once for 5 min in PSB(+/+) before incubation in secondary
antibody, diluted in 10% animal serum of the host-species of secondary
antibody in 0.1% PBST for 1 h. See supplementary Table 3. For primary
and secondary antibody dilutions. Hoechst staining was completed
where necessary (secondary only controls in the case of colocalization)
for 5 min in PBS(+/+) followed by two washes in PBS(+/+) for 5 min
per wash. Cells were then mounted onto coverslips with Prolong Gold
(P36934). Each experiment and their individual cell types included a
secondary only control that was analysed with the same laser intensities
as the treatment samples. Individual treatments were completed in three
biological replicates. Primary and secondary antibodies and their con
centrations are listed in Table 3. Supplementary videos depicting the
immunofluorescent architecture are available to download (Supple
mentary videos 1-4).
Supplementary video related to this article can be found at https://
doi.org/10.1016/j.yexcr.2021.112714

RNA isolation was completed using a RNeasy RNA isolation kit
(Qiagen 74,104) and Trizol (Ambion 15,596,018) hybrid protocol fol
lowed by DNAse treatment (Invitrogen AM1906). cDNA synthesis was
completed in accordance with iScript (BioRad 170-8891) protocols.
Total RNA was extracted from adherent cells using TRIzol Reagent
(Invitrogen) and a RNeasy mini kit (Qiagen). DNAses were then
removed using DNAse Free Kit (AM1906). cDNA synthesis using iScript.
Primers were tested in temperature gradients before cDNA dilution se
ries to determine primer efficiencies. Relative transcript abundance was
compared using mean ± SEM with a two-way ANOVA with Tukey’s
multiple comparison test with three biological replicates. Relative
transcript abundance was calculated using the Pfaffl method of quanti
fication, normalized to mESCs and relative to TATA-binding protein
(Tbp) transcript abundance. Forward and reverse primer designs and
annealing temperatures are available in Table 1.
2.5. Western blotting
Mouse ESCs and mEpiLCs were washed with cold DPBS (calcium
chloride/magnesium chloride) (PBS(+/+)) (Gibco 14,040–133) and all
cell types were lysed with Pierce™ RIPA Buffer (ThermoScientific
89,900) supplemented with 1X Phosphatase Inhibitor Cocktail Set 2
(Calbiochem 5,246,251) and 1X Protease Inhibitor Cocktail Set 1 (Cal
biochem 539,131). mEpiSCs passaged off MEF-coated plates onto
fibronectin (Roche 11,051,407,001) coated plates for a single passage
using StemPro™ Accutase™ to avoid MEF contamination. mEpiSCs
were centrifuged at 244 rcf and lysed. Lysates were sonicated for five,
30 J pulses over 30 s and were rotated at 4 ◦ C for 30 min followed by
centrifugation of 12,000 rcf at 4 ◦ C for 20 min with the supernatant
removed into a fresh, chilled tube. Protein quantification was completed
using a Pierce™ BCA Protein Assay kit (Thermo Fisher Scientific
23,225). Protein loading mixes were prepared at 10–25 g samples in
MilliQ H2O, LDS and Reducing Agent at 70 ◦ C for 10 min. Loading mixes
were loaded in NuPAGE™ 4–12% Bis-Tris Gels (Invitrogen NuPAGE
NP0336), the electroporation solution consisting of 1x MOPS (BOLT
Invitrogen B000102) and 500 L of sample reducing agent containing
dithiothreitol (Thermofisher NP0009) added. Electrophoresis was
completed at 200 V for 50 min. Proteins were transferred to a PVDF
membrane at 100 V for 2 h in ice-cold conditions. The protein trans
ferred PVDF membrane (EMD Immobilon IPVH00010) was blocked in
5% bovine serum albumin (BSA) (ALB001) for phosphorylated anti
bodies or 5% skimmed milk (Carnation) in 1x TBST for 1 h at room
temperature with end-to-end agitation. Primary antibodies were intro
duced to the membrane overnight at 4 ◦ C with rotation. Membranes
were washed 3 times for 10 min in TBST and HRP conjugated secondary
antibodies were introduced for 1 h at room temperature with rotation.
Membranes were then washed three times for 10 min each and imaged
with Luminata Classico Western HRP Substrate (EMD WBLUC0500) or
Immobilon Forte Western HRP Substrate (EMD WBLUF0500) on a
ChemiDoc. Membranes were stripped using an antibody stripping buffer
(FroggaBio ST010) until previous antibody binding was no longer
evident. Bands of interest were compared to β-ACTIN and/or Ponceau
Stain for total lane protein densitometry. Western blotting densitometry
results were compared using mean SEM, One-way ANOVA, Tukey’s
multiple comparison test with three biological replicates. Primary and
secondary antibodies and their concentrations are listed in Table 2.

2.7. Nuclear and cytoplasmic protein fractionation
Rapid isolation of nuclei from cells was completed using the REAP
protocol [75]. mESCs were grown to 90% confluency on 10 cm dishes.
Prior to collection, culture medium was aspirated, and the cells were
washed with ice-cold PBS(− /− ) with 1X Protease Inhibitor Cocktail Set
1 (Calbiochem 539,131). The PBS was aspirated, and the dish was
placed on ice where 1 mL of PBS was added, and the cells were scraped
and centrifuged for 10 s at 10,000 rpm. The supernatant was aspirated
and resuspended in 900 μL of ice-cold 0.1% Tergitol-NP-40 (Sigma
NP-40S) in PBS(− /− ) before being triturated 5 times. At this point a 300
μL total lysate sample was removed and stabilized in Laemmli buffer and
vortexed. This sample was sonicated at 20 kHz for 2 pulses each 8 s long
and the sample was then boiled for 1 min and frozen prior to western
blotting. The remaining NP-40 suspended sample was then centrifuged
at 10,000 rpm for 10 s and 300 μL was removed as the cytoplasmic
fraction. This fraction was stabilized in Laemmli buffer, vortexed and
boiled for 1 min before being frozen prior to western blotting. The
remaining NP-40 suspended sample was aspirated and resuspended in 1
mL 0.1%NP-40 in PBS(− /− ) with 1X Protease Inhibitor Cocktail Set 1
before centrifuged at 10,000 rpm. The supernatant was discarded, and
the pellet resuspended in water and Laemmli buffer before sonication at
20 kHz for 2 pulses at 8 s per pulse. This nuclear fraction was boiled for
1 min and frozen for future western blotting as described above.
NE-PER™ (ThermoFisher 78,833) nuclear and cytoplasmic fraction
ation was completed using the specified kit protocol as provided by
ThermoFisher. Antibody staining for control markers LAMIN A and
⍺-TUBULIN and the markers of interest PKM1, pPKM2 and PKM2 were
compared relative to total lane protein content by Ponceau staining
(0.1% Ponceau, 5% acetic acid). Each cell type’s mean densitometry
SEM was analysed by applying a one-way ANOVA with Tukey’s multiple
comparison test or unpaired, two tailed t-test respectively with 3 bio
logical replicates.
2.8. Colocalization: co-occurrence and correlation by
immunofluorescence
Orthogonal projections of colony optimal slice generated image
stacks were taken at 40x and 63x immersed in oil by a Zeiss LSM800
confocal microscope. Thresholds were set by optimized single stain
samples (channel 488 - OCT4, GAPDH and channel 555 - PKM1, PKM2)
exposed to all tested lasers and exposures. These exposures and laser
intensities were tested against secondary antibody only controls. Double
stains (PKM1/OCT4, PKM1/GAPDH, PKM2/OCT4, and PKM2/GAPDH)

2.6. Immunofluorescence and confocal microscopy
Cells were plated onto 1.25 mm thick coverslips coated with gelatin.
When ready, cells were fixed with 2% paraformaldehyde (PFA) (EMS
15714) in PBS(+/+) for 10 min and washed for 5 min with chilled PBS
(+/+). Following fixation, cells were permeabilized with 0.1% Triton X100 (TX1568-1) in PBS(+/+) for 10 min and washed for 5 min with
4
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were taken in stacks containing full colonies and processed into
orthogonal projections. The projections were then set to the pre
determined co-localization thresholds (Costes thresholds were set when
applicable) as set from the single stain controls. Each treatment was
analysed in at least biological triplicate and each biological replicate
was examined for several technical replicates of different colonies
within their respective samples. Double stained treatments were
compared for co-occurrence and correlation using Manders’s Overlap
Coefficient (MOC) and Pearson’s Correlation Coefficient (PCC) respec
tively. MOC and PCC represent areas of spatial overlap and correlation
between two controlled fluorophores within regions of interest respec
tively. Areas of interest and negation of background information was
completed using the outline tool to circle colonies and cells of interest
while removing staining on MEFs and potential sources of non-specific
binding. Additionally, we compared individual cells to whole colonies
using airyscan processing under 63x magnification by confocal micro
scopy. This process increased the signal-to-noise ratio thus increasing
signal resolution. Due to the intensity of light during an airyscan pro
cess, photobleaching prevented stacks of colonies at 63x when exam
ining the individual cells. PCC values were categorised within set ranges
to a classification, that included: correlation: very weak: 1 to − 0.27,
weak: 0.26–0.09, moderate: 0.1–0.48, strong: 0.49–0.84, and very
strong: 0.85–1.0 [74]. MOC values fall into set ranges of: overlap: very
weak: 0–0.49, weak: 0.50–0.70, moderate: 0.71–0.88, strong:
0.89–0.97, very strong: 0.98–1.0 [74]. Statistical analysis included
application of a two tailed Mann-Whitney test of mean SEM MOC and
PCC scores run in at least three biological and technical replicates. All
tested samples were stained and treated in the same manner and

processed in the same session. Between microscopy sessions, single stain
laser thresholds were retaken to account for any potential photo
bleaching. Statistics of PCC and MOC treatments relative to the positive
reference represent a two-way ANOVA with Sidak’s multiple compari
sons test of mean ± SEM PCC and MOC scores where ɑ = 0.05, n = 3
biological replicates.
3. Results
3.1. Characterization of naïve mESCs transitioning towards a primed
pluripotent state
By 72 h following the removal of mouse LIF and 2i supplementation
with the addition of Fgf-2/Activin A (FA media), mESCs approximating
a primed-like pluripotent state underwent an apoptotic event with the
resulting colonies transitioning to a flattened morphology (Supple
mentary Fig. 1). The mESCs by 72 h had transitioned to mEpiLCs
(primed-like state) and the mESCs, mEpiLCs, and mEpiSCs showed ho
mogenous colony expression of the pluripotency associated genes
NANOG, OCT4, and SOX2 (Fig. 1A). Secondary antibody only controls
confirmed the specificity of the immunofluorescence staining (Supple
mentary Fig. 2).
Assessment of stage specific transcript abundance of naïve, forma
tive, and primed markers verified the pluripotent state of mESCs,
mEpiLCs, and mEpiSCs, respectively (Fig. 1). The naïve pluripotent
associated genes: Rex1, Esrrb, Pecam, Tcfcp2l1, Klf2, Klf4, Dppa3, and
Klf5 all underwent a significant (p < 0.05) reduction in transcript
abundance in mEpiLCs and mEpiSCs relative to mESCs (Fig. 1B). The

Fig. 1. mESC, mEpiLC, and mEpiSC populations transcript abundance for pluripotency genes. . (A) Immunofluorescence of mESC, mEpiLC, and mEpiSC stained with
Hoechst (blue), phalloidin (red), and the core pluripotency associated markers (green): NANOG, OCT4, SOX2 assessed by confocal microscopy. Images taken using
40x magnification and scale bars represent 20 μm. (B) Histogram of transcript abundance of naïve, formative, and primed pluripotent associated genes relative to Tbp
and normalized to mESCs. Error bars represent standard error of the mean (SEM), n = 3, *p < 0.05. Statistics for the transcript abundance study represent a two-way
ANOVA with Tukey’s multiple comparisons of mean ± SEM where ∝ = 0.05, n = 3 biological replicates run in technical triplicate.
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transcript abundance of formative pluripotent associated genes; Lef1,
Dnmt3, and Pou1fc were significantly (p < 0.05) increased in mEpiLCs
compared to mESCs with Dnmt3 and Pou1fc mRNAs also significantly
(p < 0.05) elevated in mEpiLCs over that observed in mEpiSCs (Fig. 1B).
The transcript abundance of primed pluripotent state associated markers
Zic2, T (Brachyury), and Cer1 were significantly (p < 0.05) increased in
the mEpiSCs relative to the mESCs (Fig. 1B).

naïve mESCs were transitioned to formative, primed-like mEpiLCs.
However, no significant (p > 0.05) difference in the ratio of PKM1 to
PKM2 protein abundance relative to β-ACTIN was observed in any
pluripotency cell state cultures investigated. PKM1 and PKM2 protein
fluorescence were detected in the cytoplasm and nuclei of mESCs,
mEpiLCs, and mEpiSCs as demonstrated by morphological comparison
with Hoechst and rhodamine phalloidin stains representing nuclear and
cytoskeletal compartments respectively (Fig. 2B). Secondary antibody
only controls confirmed the specificity of the PKM1/2 immunofluores
cence staining (Supplementary Fig. 3).

3.2. PKM1/2 protein abundance and localization fluctuate in naïve
mESCs, primed-like mEpiLCs, and primed mEpiSCs
We detected a significant (p < 0.05) increase in PKM1 and PKM2
protein abundance relative to β-ACTIN in formative primed-like
mEpiLCs cultured in Fgf-2/Activin A (FA medium) compared to naïve
mESCs or primed mEpiSCs (Fig. 2A). The ratio of phosphorylated
(Tyr105), homodimeric conformation of PKM2 to total PKM2 protein
abundance relative to β-ACTIN significantly (p < 0.05) decreased when

3.3. Qualitative PKM1/2 nuclear translocation in naïve mESCs,
formative mEpiLCs, and primed mEpiSCs
Nuclear PKM1/2 was not always clearly visible in colonies or indi
vidual cells, this led us to taking a 3-Dimension (3D) approach to im
aging. Using a confocal microscope, individual slices of fluorescent

Fig. 2. Distinct PKM1 and PKM2 protein profiles in mESCs, mEpiLCs, and mEpiSCs. A) Histogram comparing protein abundance of PKM1, PKM2, and pPKM2 relative
to β-ACTIN in mESCs, mEpiLCs, and mEpiSCs in total protein lysates. Error bars represent SEM, n = 3, *p < 0.05. B) Immunofluorescence of mESC, mEpiLC and
mEpiSC stained for Hoechst (blue), phalloidin (red), and the metabolic markers: PKM1 and PKM2 (green) assessed by confocal microscopy. Images taken using 40x
magnification and scale bars represent 20 μm. Error bars represent SEM, n = 3, *p < 0.05. Statistics represent a one-way ANOVA with Tukey’s multiple comparisons
of mean ± SEM MOC and PCC scores run in n = 3 biological replicates.
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images were stacked to generate a 3D structure of entire colonies of
mESCs and mEpiSCs for PKM1 and PKM2 (Supplementary Fig. 4).
Visually examining the 3D architecture of mESCs stained for PKM1
provides our first truly promising evidence of nuclear PKM1 trans
location as cells closer to the upper layers of the colony exhibit clear
nuclear localization. Video files examining slices of PKM1 and PKM2 in
mESCs and mEpiSCs with staining for nuclear and cytoplasmic regions
can be found in Supplementary videos 1-4.
To further promote the notion of nuclear translocation of PKM1/2 in
mESCs and mEpiSCs, we utilized the pharmacological agent Leptomycin
B. Leptomycin B is an antibiotic and the first agent found that works to
block nuclear export in cells (Wolff, Sanglier, and Wang 1997). As
Leptomycin B doesn’t impede nuclear import, it served as a useful tool in
the study of nuclear PKM1/2 translocation. Leptomycin was first
assessed in a time course (Supplementary Fig. 7 - 7.). As small colonies
visually appeared to show the most consistent nuclear PKM1, we
examined the influence of adding the nuclear export blocking agent
Leptomycin B in mESCs over 3, 6, 9, and 12 h comparing no Leptomycin
to 2 ng/mL treatments by fluorescent imaging. From these images we do
see increased nuclear PKM2 at 12 h (Supplementary Fig. 5) and PKM1
throughout the series (Supplementary Fig. 6).
We then proceeded to increase the concentration of Leptomycin B to
better demonstrate nuclear localization in larger colonies. Examining
mESCs at 5 and 10 h following the addition of 20 μg/mL of Leptomycin B
showed clearer nuclear translocation of PKM1 at 10 h relative to no
Leptomycin B treatment (Supplementary Fig. 7). The addition of nuclear
and cytoplasmic markers further allowed for a comparison of nuclear
translocation. SOX2, Hoechst and phalloidin made comparing nuclear
PKM1 substantially more evident. It was clear that blocking nuclear
export in these cells was detrimental to their viability and not a longterm solution.
Finally, we examined both naïve mESCs and primed mEpiSCs for
PKM1 and PKM2 protein localization by fluorescent imaging with the
addition of 20 μg/mL Leptomycin B (Supplementary Fig. 8). This im
aging provided evidence that not only naïve mESCs experience nuclear
translocation, but primed mEpiSCs, exhibiting the aerobic glycolytic
metabolic preference also have a degree of PKM1 and PKM2 nuclear
translocation. We originally hypothesized that primed mEpiSCs would
have nuclear PKM2 as this localization pattern is indicative of dimeric
pPKM2 and the Warburg Effect [27,60]. Nuclear translocation of PKM1
and PKM2 in either end of the pluripotent continuum naturally led us to
investigate what happens in between the naïve and primed states, and
ultimately devise a better system of colocalization methodology.

nuclear PKM1 protein abundance in formative state mEpiLCs (Supple
mentary Fig. 10). This further validated pursuing the colocalization
strategy central to this study.
3.5. Subnuclear localization of PKM1 and PKM2 with OCT4 within naïve
mESCs
To authenticate the subcellular immunofluorescence results
(Fig. 2B), we performed a colocalization study investigating spatial cooccurrence or overlap and correlation of PKM1 and PKM2 with the
nuclear localized marker OCT4 and the cytoplasmic localized marker
GAPDH using confocal microscopy. Colocalization of immunofluores
cent spatial overlap and correlation was compared using Manders’s
overlap coefficient (MOC) and Pearson’s correlation coefficient (PCC),
respectively, applied on orthogonal projections with background pixels
removed from quantification [66]. Using these methods, total mESC
colony colocalization of PKM1 and PKM2, relative to OCT4 and GAPDH
showed a high instance of spatial overlap to both marker proteins with a
significantly (p < 0.05) greater overlap to nuclear OCT4 (Fig. 3A and B).
However, PKM1 displayed significantly (p < 0.05) higher correlation to
OCT4 localization compared to GAPDH (Fig. 3B). Using the standards
set by Zinchuk et al., PKM1 and PKM2 exhibited a ‘moderate’ correlation
and a ‘strong’ overlap to both OCT4 and GAPDH localization (PCC
range: moderate = 0.1–0.48, MOC range: strong = 0.89–0.97) [74]. By
increasing the signal-to-noise ratio through airyscan processing, the
colocalization resolution was improved and the analysis was applied to
individual mESCs. Individual cell analysis aligned closely with the col
ony analysis by indicating a strong correlation for spatial co-occurrence
for PKM1 and PKM2 in mESCs (Supplementary Fig. 12A and B).
Immunofluorescence controls and colocalization thresholds are shown
in Supplementary Fig. 11.
3.6. Subnuclear localization of PKM1 and PKM2 with Oct4 in mEpiLCs
Immunofluorescent colocalization was quantified in mEpiLCs
cultured in transitioning FA medium at 48 h via confocal microscopy of
orthogonal projections and airyscan processing. These cells represent
the formative pluripotent state. We applied both total colony and single
cell colocalization analysis as described above and observed cooccurrence of PKM1 and PKM2 compared to OCT4 and GAPDH with a
significantly (p < 0.05) greater PKM1 spatial co-occurrence to OCT4
(Fig. 4A and B). Only PKM1 localization was correlated with both OCT4
and GAPDH localization in these cultures (Fig. 4B). PKM1 exhibited a
‘strong’ correlation and a ‘strong’ overlap with OCT4 localization, a
‘moderate’ correlation and a ‘strong’ overlap to GAPDH localization
(PCC range: strong = 0.49–0.84, MOC range: strong = 0.89–0.97) [74].
PKM2 displayed a ‘weak’ correlation to both OCT4 and GAPDH with a
‘strong’ overlap to OCT4 and a ‘moderate’ overlap to GAPDH (PCC
range: weak = − 0.26–0.09, MOC range: moderate = 0.71–0.88, strong
= 0.89–0.97). Using airyscan processing, individual cells of mEpiLC
colonies displayed consistent correlation and spatial overlap compared
to the colony in total (Supplementary Fig. 14A and B). Immunofluo
rescence controls and colocalization thresholds are shown in Supple
mentary Fig. 13.

3.4. Nuclear localization of PKM1 and PKM2 in naïve mESCs and
mEpiLCs by cell fractionation
Initial results of nuclear PKM1/2 were demonstrated by a nuclear
and cytoplasmic protein fractionation of naïve mESCs using an NE-PER
kit and the REAP protocol [75]. Our results indicated a nuclear presence
of our proteins of interest, however high purity of the nuclear and
cytoplasmic fractions was not achieved. Naïve mESCs were selected as
they were the only mPSC that exhibited both a nuclear co-occurrence
and correlation of PKM1 and PKM2 with OCT4 immunofluorescence
from our colocalization study. The REAP protocol was validated by
comparing the nuclear and cytoplasmic protein fractions with the nu
clear marker LAMIN A and the cytoplasmic marker ⍺-TUBULIN. We
observed a significant (p < 0.05) increase in ⍺-TUBULIN in the cyto
plasmic fraction compared to the nuclear fraction validating successful
fractionation (Supplementary Fig. 9. A, B, C). The results effectively
demonstrated the nuclear localization of PKM1 from naïve mESC protein
lysates (Supplementary Fig. 9C). This was evident as the ratio of nuclear
to cytoplasmic fraction PKM1 trended towards elevated levels of nuclear
PKM1 in the mESC, however this did not reach statistical significance
(Supplementary Fig. 9C). Using an NE-PER™ nuclear and cytoplasmic
fractionation kit, we observed a significant (p < 0.05) increase in

3.7. Subnuclear localization of PKM1 and PKM2 with Oct4 in mEpiSCs
As observed for the naïve mESCs and the formative mEpiLCs, we
observed a high degree of PKM1 and PKM2 spatial overlap to both OCT4
and GAPDH in mEpiSCs (Fig. 5A and B). However, unlike the mESCs and
mEpiLCs, there were only low levels representing no meaningful cor
relation of PKM1 or PKM2 with OCT4 or GAPDH in these cultures
(Fig. 5A and B). PKM1 and PKM2 immunofluorescence each showed a
‘strong’ overlap to both OCT4 and GAPDH immunolocalizations (MOC
range: 0.89–0.97) [74]. PKM1 and PKM2 displayed a ‘weak’ correlation
to OCT4 and a ‘moderate’ correlation to GAPDH (PCC range: weak =
7
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Fig. 3. PKM1 and PKM2 are translocated to the nuclei of mESCs, and both PKM1 and PKM2 are associated with OCT4 and GAPDH localization. (A) Immunoflu
orescence of mESCs stained for OCT4 (green), GAPDH (green), and PKM2 (orange) for a confocal, colocalization analysis. Images taken using 40x magnification and
scale bars represent 20 μm. Histogram comparing PKM2 to OCT4 and GAPDH spatial localization by Manders’s Overlap Coefficient (MOC) and Pearson’s Correlation
Coefficient (PCC). Error bars represent SEM, n = 3, *p < 0.05. (B) Immunofluorescence of mESCs stained for OCT4 (green), GAPDH (green), and PKM1 (orange) for a
confocal, colocalization analysis. Images taken using 40x magnification and scale bars represent 20 μm. Histogram comparing PKM1 to OCT4 and GAPDH spatial
localization by Manders’s Overlap Coefficient (MOC) and Pearson’s Correlation Coefficient (PCC). Error bars represent SEM, n = 3, *p < 0.05. Statistics represent a
two tailed Mann-Whitney test of mean ± SEM MOC and PCC scores run in n = 4 biological replicates and at least a technical triplicate.

− 0.26–0.09, moderate = 0.1-0.48). Using airyscan processing, individ
ual cells of mEpiSC colonies displayed consistent correlation and spatial
overlap compared to the colony in total (Supplementary Fig. 16A and B).
Immunofluorescence controls and colocalization thresholds are shown
in Supplementary Fig. 15.

and PKM2 during transitioning mESCs, mEpiLCs, and mEpiSCs cultures,
we contrasted the outcomes between overall correlation (PCC) with
Hoechst and OCT4 (positive reference), and Hoechst and GAPDH
(negative reference). Each mPSC state examined showed differential
PKM1/2 subnuclear expression correlation to OCT4 and GAPDH
compared to the positive reference. Relative to the positive reference
indicating nuclear OCT4 association, there was no significant (p > 0.05)
difference in PCC of PKM1 or PKM2 localization to OCT4 or GAPDH in
mESCs (Fig. 6B). In contrast, mEpiLCs and mEpiSC displayed signifi
cantly (p < 0.05) less PCC of PKM2 localization to OCT4 relative to the
positive reference, however, these values did not reach a meaningful
linear correlation level (Fig. 6B). Relative to the positive reference
indicating nuclear association, there was no significant (p > 0.05) PCC
difference in PKM1 and a significant (p < 0.05) decrease in correlation
of PKM2 localization to OCT4 and GAPDH localization relative to the
positive reference in mEpiLCs, suggesting nuclear association of PKM1
and reduced nuclear association of PKM2 with OCT4 (Fig. 6B). Relative
to the positive reference indicating nuclear association, there was a
significant (p < 0.05) decrease in PCC of PKM1 and PKM2 localization to
OCT4 and GAPDH localization relative to the positive reference in
mEpiSCs (Fig. 6B). However, in the case of mEpiLCs and mEpiSCs,
values with PCC = 0 reflect no meaningful linear correlation and we
cannot conclusively infer meaningful association of PKM1 or PKM2
localization to these fluorophores of interest.
Using the standard ranges set by Zinchuk et al. to describe these
values with qualifying terms, we observed a ‘strong correlation’ and

3.8. PKM1 and PKM2 are differentially localized to OCT4 and GAPDH
between naïve, formative, and primed pluripotent states
To obtain a deeper understanding of the cellular co-occurrence of
nuclear PKM1 and PKM2 during the transition from mESCs, mEpiLCs
and mEpiSCs cultures we contrasted the outcomes between overall cooccurrence (MOC) with Hoechst and OCT4 (positive reference) and
Hoechst and GAPDH (negative reference). Relative to the positive
reference, there was no significant (p > 0.05) changes to MOC of PKM1
or PKM2 localization to OCT4 localization in mESCs, mEpiLCs or
mEpiSCs, indicating that PKM1 and PKM2 do indeed occupy nuclear
associated regions in these pluripotent cells (Fig. 6). Relative to the
positive reference, there was a no significant (p > 0.5) changes to the
MOC of PKM1 or PKM2 localization to GAPDH localization in mESCs
and mEpiSCs, indicating that PKM1 and PKM2 do indeed occupy cyto
plasmic regions in these cells as well (Fig. 6B). However, relative to the
positive reference, there was a significant (p < 0.05) decrease in MOC of
PKM1 and PKM2 localization to GAPDH localization in the mEpiLCs,
indicating a decreased cytoplasmic presence in these cells (Fig. 6B).
To further interrogate the subnuclear association of nuclear PKM1
8
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Fig. 4. PKM1 and PKM2 are translocated to the nuclei of mEpiLCs, and PKM1 is associated with OCT4 and GAPDH localization. A) Immunofluorescence of mEpiLCs
stained for OCT4 (green), GAPDH (green) and PKM2 (orange) for a confocal, colocalization analysis. Images taken using 40x magnification and scale bars represent
20 μm. Histogram comparing PKM2 to OCT4 and GAPDH spatial localization by Manders’s Overlap Coefficient (MOC) and Pearson’s Correlation Coefficient (PCC).
Error bars represent SEM, n = 3. (B) Immunofluorescence of mEpiLCs stained for OCT4 (green), GAPDH (green), and PKM1 (orange) for a confocal, colocalization
analysis. Images taken using 40x magnification and scale bars represent 20 μm. Histogram comparing PKM1 to OCT4 and GAPDH spatial localization by Manders’s
Overlap Coefficient (MOC) and Pearson’s Correlation Coefficient (PCC). Error bars represent SEM, n = 3, *p < 0.05. Statistics represent a two tailed Mann-Whitney
test of mean ± SEM MOC and PCC scores run in at least n = 3 biological replicates and at least technical triplicate.

‘strong overlap’ in the Hoechst/OCT4 positive reference (PCC = 0.49±
0.06, MOC = 0.95± 0.00) and a ‘very weak correlation’ and ‘strong
overlap’ in the GAPDH/Hoechst negative reference (PCC = − 0.07±
0.08, MOC = 0.89±0.01) (Fig. 6A) [74]. These standards promote the
superiority of the PCC over the MOC, however, we did see significant
differences between our positive and negative references and our sample
data indicating a valuable role for the MOC comparison as well.
In summary, PKM1 and PKM2 occupy the same spatial localization as
OCT4 nuclear regions and differentially correlate to subnuclear locali
zations relative to OCT4 and GAPDH localization in mESCs, mEpiLCs
and mEpiSCs. We demonstrate that both the PCC and MOC metrics are
valuable in comparison to known positive nuclear references, in this
case Hoechst staining. Reference stains and colocalization thresholds are
available in Supplementary Fig. 17.

phosphorylated PKM2 in the formative state. Despite this increase in
protein abundance, the ratio of PKM1 to PKM2, a common ratio used to
examine aerobic glycolytic preferential cancer cells, was not different
between each pluripotent state, indicating that a stable PKM1-to-PKM2
ratio is likely required for maintaining pluripotency [40]. We observed
nuclear immunofluorescence for both PKM1/2 isoforms in naïve mouse
embryonic stem cells (mESCs), formative mouse epiblast-like stem cells
(mEpiLCs), and primed mouse epiblast stem cells (mEpiSCs).
Prompting our colocalization study, we examined nuclear and
cytoplasmic fractionation protein abundance in the mESCs. Due to the
inherent difficulty of nuclear and cytoplasmic extraction and the
exceptionally high nuclear-to-cytoplasmic ratio of mESCs, we eventually
found a successful method of extraction, the REAP (Rapid, Efficient, and
Practical) methodology [75,76]. While nuclear extraction of PSCs is
generally considered a challenging technique, clean extractions have
been published [77]. Using this technique, we were able to determine
that PKM1 and PKM2 do have increased nuclear lysate protein abun
dance. The most important finding of this study was that PKM1 is
enriched in the nuclear fraction compared to the cytoplasmic fraction of
mESCs, further supporting that PKM1 is being translocated to the nuclei
of naïve mESCs.
To verify this observation, we devised a confocal colocalization
approach to compare differences in nuclear and cytoplasmic localization
by contrasting orthogonal projections with well-established reference
markers. Using this technique, we determined that in each pluripotent
state, PKM1 and PKM2 both reside in nuclear regions and that PKM1 and

4. Discussion
Despite traditionally being considered a passive trait of cell-fate
determination, mounting evidence now supports metabolism as hav
ing a direct role in self-renewal, cell fate, and differentiation [39]. Our
study investigated differences in pyruvate kinase muscle isoforms 1 and
2 (PKM1/2) in naïve, formative, and primed pluripotent stem cells and
found differential expression and nuclear localization of these metabolic
isoforms during pluripotent state transitioning. Densitometry of total
protein lysates indicated that over the course of pluripotent progression
there is an increased protein abundance of PKM1, PKM2, and
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Fig. 5. PKM1 and PKM2 are translocated to the nuclei of mEpiSCs, and neither isoform is associated with OCT4 or GAPDH localization. (A) Immunofluorescence of
mEpiSCs stained for OCT4 (green), GAPDH (green) and PKM2 (orange) for a confocal, colocalization analysis. Images taken using 40x magnification and scale bars
represent 20 μm. Histogram comparing PKM2 to OCT4 and GAPDH spatial localization by Manders’s Overlap Coefficient (MOC) and Pearson’s Correlation Coef
ficient (PCC). Error bars represent SEM, n = 3. (B) Immunofluorescence of mEpiSCs stained for OCT4 (green), GAPDH (green), and PKM1 (orange) for a confocal,
colocalization analysis. Images taken using 40x magnification and scale bars represent 20 μm. Histogram comparing PKM1 to OCT4 and GAPDH spatial localization
by Manders’s Overlap Coefficient (MOC) and Pearson’s Correlation Coefficient (PCC). Error bars represent SEM, n = 3. Statistics represent a two tailed MannWhitney test of mean ± SEM MOC and PCC scores run in at least n = 3 biological replicates and at least technical triplicate.

PKM2 are moderately associated with OCT4 localization patterns in
mESCs. PKM1 is strongly associated with OCT4 localization patterns in
mEpiLCs and both isoforms have a weak association to OCT4 immuno
localization in mEpiSCs showing a progressive decline in association to
the pluripotency gene OCT4 during mouse ES cell pluripotency
transitioning.
The measurement of colocalization is a complicated and hotly
debated area of biology [72,73]. The term colocalization is largely used
to measure two main components with different applications, namely
correlation or co-occurrence of two fluorophores to each other based on
pixel distribution [69]. Co-occurrence in immunofluorescence is the
presentation of fluorescent pixels existing in the same spatial distribu
tion, and it is an indicator of overlap between markers [68]. Correlation
is a measurement of the relationship between the pixel intensities and
may indicate a biochemical interaction [68]. Both the Manders’s overlap
coefficient (MOC) and Pearson’s correlation coefficient (PCC) are valid
measures of colocalization, but they inform different biological ques
tions [72]. Immunofluorescence microscopy is commonly thought of as
a qualitative technique and the literature into colocalization often uses
descriptors such as ’moderate’ or ’strong’ association within PCC
ranges. Zinchuk et al. developed a method of colocalization range de
scriptors to bring greater consistency to the field and offer more validity
to the quantitative nature of colocalization [74]. We implemented this
approach to assign a quantitative designate to the colocalization of
PKM1 and PKM2 within the mPSCs of this study. Our study supports
claims that the MOC is a valuable metric of colocalization. By comparing

MOC and PCC values to a positive and negative biological reference, we
were able to set a stronger baseline than using only improved de
scriptors. We used well recognized nuclear (OCT4) and cytoplasmic
(GAPDH) proteins as control markers to compare to another known
nuclear stain, Hoechst, which, set a positive and negative reference to
nuclear colocalization that allowed us to directly compare MOC and PCC
values to. Comparing our known positive and negative references to the
qualifying range standards set by Zinchuk et al. our data supports that
comparing colocalization by correlation is superior to spatial overlap in
our system [74]. However, while MOC still provided valuable knowl
edge, the PCC data showed an improved distinction between internal
reference controls. Our findings demonstrate that it is critical to run
positive and negative references relative to dual fluorophore colocali
zation and that in the case of mouse embryonic stem cells, the spatial
overlap data may not be sufficient to reach quality colocalization
assessment compared to correlation data when considering the quali
fying standards set by Zinchuk et al. [74]. We observed that the MOC
metric in mPSCs did not delineate nuclear and cytoplasmic distinctions
by colocalization and that the PCC metric was a highly effective and
viable tool for such distinction and analysis. To increase the power of
our colocalization study, we did not simply analyze single images but
employed orthogonal projections of stacks examining the data of indi
vidual slices to characterize the localization patterns of a true
three-dimensional structure. We also accounted for the inherent flaws of
the MOC calculation by examining only the individual colonies and
individual cells in the orthogonal and airyscanned images respectively
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Fig. 6. PKM1/2 are moderately associated with OCT4 localization in mESC, PKM1 is strongly associated with OCT4 localization in mEpiLCs, and PKM1/2 overlap in
nuclear regions of mESCs, mEpiLCs and mEpiSCs. . (A) Immunofluorescence of mESCs immuno-stained for OCT4 (green), GAPDH (green), and Hoechst (blue) for a
confocal, colocalization analysis. Images taken using 40x magnification and scale bars represent 20 μm. Histogram comparing Hoechst to OCT4 and GAPDH spatial
localization by Manders’s Overlap Coefficient (MOC) and Pearson’s Correlation Coefficient (PCC). Error bars represent SEM, n = 3. (B) Total results of colocalization
study comparing positive and negative references to mESCs, mEpiLCs, and mEpiSC MOC and PCC values. Standard range qualifiers set by Zinchuk et al. (2013)
compare overlap and correlation differences. Error bars represent SEM, n = 3. Statistics of PCC and MOC treatments relative to the positive reference represent a twoway ANOVA with Sidak’s multiple comparisons test of mean ± SEM PCC and MOC scores where ∝ = 0.05, n = 3 biological replicates.

to prevent autofluorescence or background pixel offset to influence the
algorithm.
Naïve mESCs, in the metabolically bivalent state, proved to be a
unique and attractive cell type for colocalization analysis. By examining
the correlation of PKM1 and PKM2 immunolocalizations to OCT4 and
GAPDH immunolocalizations, we were able to assess not only if the PKM
isoforms were occupying similar spaces, but if the trends in subnuclear
pixel intensity were related as well. Not only did both isoforms occupy
the same spatial regions in comparison to the controls, but both PKM1
and PKM2 were clearly associated with the localization patterns of both
OCT4 and GAPDH. Together, these results promote the concept that
PKM1 and PKM2 both translocate to the nuclei of mESCs. A recent study
using mass spectroscopy of human lung carcinoma cells determined that
PKM1 and PKM2 interact with each other suggesting a possible PKM1/2
interaction in the nuclei of mouse ESCs [63]. This was supported in our

REAP fractionation study of nuclear and cytoplasmic protein abundance
in mESCs which demonstrated the presence of both PKM1 and PKM2 in
nuclear fractions [75]. This methodology was able to cleanly discrimi
nate cytoplasmic fractions from nuclear proteins as controlled by LAMIN
A, however, nuclear fractions were not fully separated from cytoplasmic
proteins, likely due to the high -nuclear-tocytoplasmic size ratio in PSCs.
In our initial PKM protein abundance characterization of total cell
lysate we found that there was an increase of PKM1 and PKM2 levels in
mEpiLCs. Despite this increase in protein abundance, the ratio of PKM1
to PKM2 protein abundance did not change between any of the plurip
otent cell types examined. As PKM2 switches to increased PKM1
expression during differentiation and development, with the reverse
occurring during tumor formation, the role of the PKM1 to PKM2 ratio
has become a focus of interest [78]. It may be more pertinent to examine
the nuclear to cytoplasmic ratio of PKM1/2 including the dimer to
11

J.G. Dierolf et al.

Experimental Cell Research 405 (2021) 112714

tetramer conformations of PKM2 in various pluripotent states. Surpris
ingly, the formative state mEpiLCs had significantly decreased in PKM1
and PKM2 colocalization spatial overlap to GAPDH compared with the
positive reference. This demonstrates very low amounts of either iso
form occupying the traditional cytoplasmic region occupied by GAPDH
for both isoforms. When examining mEpiLCs for correlation of PKM1
and PKM2 colocalization to OCT4 and GAPDH, we determined that
PKM1 was associated with both OCT4 and GAPDH compared to the
controls. Coupling this finding with the results of the colocalization
overlap findings, the formative state mEpiLCs were unique in primarily
localizing PKM1 in the nucleus, suggesting that PKM1 may be key in the
transition of bivalent metabolism to preferential aerobic glycolysis.
Previous studies have shown that the transcription factor promyelocytic
leukemia protein (PML), a known PKM2 mediator that maintains the
homotetrameric conformation and suppresses the Warburg Effect, in
teracts with OCT4 and NANOG and is necessary for maintaining naïve
pluripotency [79–81]. Knocking down or deleting PML resulted in flat,
slower growing mESC colonies with reduced OCT4, SOX2, cMYC and
NR0B1 and diminished naïve-associated BMP, LIF/STAT3 and PI3K
signaling whereas Activin A and FGF signaling increased [79]. Over
expression of PML resists mESC transitioning towards primed pluripo
tency and is required for efficient iPSC generation [79]. Future studies
should examine the influence of PML in the generation of formative state
mEpiLCs. As mEpiLCs are the only cells currently described that can
efficiently give rise to primordial germ-like cells, PML and PKM1/2 may
be important targets for controlling cell fate to efficiently produce
mEpiLCs [14].
Finally, our colocalization study of mEpiSCs was quite revealing. We
determined that of all the mPSCs we studied, the primed mEpiSCs had
the greatest spatial overlap as assessed by Manders’s overlap coefficient
(MOC) of PKM1 and PKM2 colocalization to OCT4 and GAPDH yet
significantly lower PKM1 and PKM2 correlation (PCC) to OCT4 and
GAPDH. This was somewhat surprising as other Warburgian cells such as
glioma stem cells display an interaction between PKM2 and OCT4 [54].
The reduced association as assessed by the Pearson correlation coeffi
cient (PCC) of PKM2 and OCT4 may reflect differential chromatin tar
gets in the primed pluripotent state and may be associated with lineage
priming and reduced differentiation potential [54]. Interestingly, there
is also a decrease in PKM1 correlation to OCT4 as assessed by PCC, but
only in the primed mEpiSCs. Using our refined colocalization analysis
we show that PKM1 and PKM2 co-occur (MOC) in the nuclei of mPSCs
across the pluripotent continuum and that PKM1 and PKM2 are differ
entially correlated (PCC) with OCT4 and GAPDH in each examined
pluripotent state. Our findings suggest that ChIP-sequencing of PKM1
and PKM2 targets should be examined in mPSC varieties encompassing
the pluripotent continuum. Further, the correlation of PKM2 colocali
zation to OCT4 decreases from naïvety, through the formative state, and
into primed pluripotency. As such, we conclude that nuclear PKM1 and
PKM2 are implicated as contributors to the maintenance and progres
sion of embryonic stem cell pluripotency.
Recent literature has reported instances of nuclear and mitochon
drial translocation of PKM2 [82,83]. The nuclear translocation of PKM2
is implicated in the regulation of the master glycolysis regulator HIF-1⍺
[59]. Jumonji C Domain-containing dioxygenase 5 (JMJD5)-PKM2
interaction hinders PKM2 tetramer formation, blocks pyruvate kinase
activity and promotes translocation of PKM2 into the nucleus to regulate
HIF-1⍺-mediated gene transcription [59]. JMJD5 regulates the cell cycle
and maintains pluripotency in human embryonic stem cells, however its
role in the nuclear translocation of PKM2 and regulating metabolism in
pluripotent stem cells has not been explored [84]. Overexpression of
PKM2 maintains the undifferentiated state by fine tuning redox control
in naïve mESCs grown as embryoid bodies [85]. Future studies treating
naïve stem cells with pharmacological agents such as shikonin or
DASA-58, which promote the tetrameric conformation of PKM2, may
resist formative state transitioning by maintaining the naïve state [64,
86]. Adjusting PKM2 levels has been completed in mESCs and a

complete knockout should be feasible as PKM2-null mice are viable
though they experience some metabolic distress and have a reliance on
PKM1 [87]. However, these mice show induction of late onset formation
of spontaneous hepatocellular carcinomas [87]. PKM2 is certainly a
potential target for cancer treatments and likely a key player in cellular
reprogramming and differentiation [40,87]. Despite several
non-canonical roles being characterized, it is likely that other roles exist
and have yet to be discovered [60,62].
While PKM2 has been extensively studied in cancers and stem cells,
the PKM1 isoform has not been investigated to the same extent [78,85,
87–91]. There is a growing body of evidence to suggest that PKM1 may
play an important role in early differentiation and within specific cancer
subtypes. Until recently, PKM1 was thought to be only expressed with
spatial heterogeneity in non-proliferative cells of tumors, however
recent publications have found this is not always the case [58,78]. PKM1
is essential for the proliferation and tumor-promoting capabilities of
small cell lung cancer (SCLCs) and other net endocrine tumors [78].
Oxygen consumption in PKM1 overexpressed cancer cells does not
change although there are more mitochondria with a greater rate of
mitochondria dysfunction, while there are more reactive oxygen species
generated in the PKM2 overexpressed cells compared to the PKM1
overexpressed cells [78]. These characteristics of PKM1 overexpressed
cells are accompanied with increased autophagic flux and increased
tumor growth with increased autophagy and mitophagy [78]. PKM1
could play a non-canonical role in promoting autophagic and mito
phagic roles during pluripotent stem cell state transitioning. When
either PKM1 or PKM2 was overexpressed in mESCs, it was found that the
pluripotency markers Nanog, Eras, and Rex1 were upregulated, and an
embryoid body formation assay showed that overexpression did not
influence differentiation [27]. Taken together, these results indicate that
PKM1 contributes to proliferation, stemness and pluripotency. Based on
our protein abundance analysis PKM2 or both isoforms may promote the
generation of mEpiLCs and the formative pluripotent state [40]. Our
results suggest that preserving the ratio of PKM1 to PKM2 may be
necessary to maintain mouse pluripotency. Such a trend is not found
following lineage specialization into various somatic cells [40]. We also
report a unique localization of PKM1 that suggests a novel,
non-canonical role just as nuclear, dimeric pPKM2 has been implicated
in several non-metabolic roles associated with stemness and cell growth
[51]. Recently, the role of PKM1 in highly proliferative cells has been
highlighted [78]. These results along with our current data questions
PKM2’s role as the traditional prototypic isozyme of development as it is
now clear that PKM1 is expressed and likely has non-canonical roles
[78]. Nuclear PKM1 has recently been reported in other highly prolif
erative cell types such as human liver cancer cells (HepG2 and
SMMC-7721) [57]. Following treatment with drug Oroxylin A (OA), an
O-methylated flavonoid derived from the Oroxylum indicum tree, PKM1
is translocated to the nucleus with hepatocyte nuclear factor 4α (HNF4α)
and increases the PKM1 to PKM2 ratio resulting in hepatoma differen
tiation [57]. PKM1 overexpressed in embryoid bodies generated from
mESCs resulted in increased endoderm transcript abundance of FOXA2,
AFP, and HINF1B, implicating PKM1 in endoderm differentiation [85].
Given our colocalization findings, the nuclear localization of PKM1 is
certainly implicated in formative state generation and the addition of a
drug such as OA may modulate the occurrence of this transient plurip
otent state.
In summary, we have demonstrated differential nuclear and subnu
clear localization of both PKM1 and PKM2 in mouse pluripotent stem
cells and suggest a novel regulatory role for nuclear PKM1. We have
established differential nuclear, subnuclear, and cytoplasmic association
of PKM1 and PKM2 in mESC cells as they transition from naïve plurip
otency, through formative state (primed-like mEpiLCs), towards primed
mEpiSCs (Fig. 7.). We suggest that protein colocalization studies applied
to PSCs should give greater weight to their correlation data and not their
spatial overlap findings especially if the standards set by Zinchuk et al.
are implemented [74]. The presence of nuclear PKM1/2 and the
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Fig. 7. PKM1/2 are differentially localized
to subcellular regions with potential inter
action with OCT4 and GAPDH in naïve,
formative, and primed mouse embryonic
stem cells. Pyruvate kinase muscle isoforms
are localized to nuclear regions in mESCs,
mEpiLCs, and mEpiSCs. There is indication
of potential biomolecular interaction of PKM
with OCT4 or GAPDH denoted by circled
proteins overlapping in the schematic. As
mESCs become more developmentally line
age primed for differentiation (mEpiSCs),
the correlation of PKM1/2 with OCT4 and
GAPDH decreases. This could mean
decreased potential for biomolecular inter
action of the isoforms with OCT4 and a po
tential
rearrangement
of
subcellular
localization patterns in the cytosol such as
mitochondrial colocalization as demon
strated in previous studies [83]. Created
with BioRender.com

dynamic redistribution of PKM1 and PKM2 within the pluripotency
continuum suggests potential non-canonical roles for both isoforms in
maintaining and directing varying pluripotent states.
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